TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy November 30, 2012